re: Trump Has ‘Financial Interest’ in Hydroxychloroquine Manufacturer

– Infectious diseases
Antibiotics:
Amoklavin (Amoxicillin/clavulanic acid)
Claforan (Cefotaxime)
Priftin (Rifapentine)
Suprax (Cefixime)
Tavanic (Levofloxacin)
Vaccines:
Bacterial diseases:
ActHIB (Hib vaccine)
Adacel (DPT vaccine)
Daptacel (DPT vaccine)
Dengvaxia (Dengue vaccine)
Menactra (Meningococcal infections)
Mycobax (Tuberculosis vaccine)
Pentacel (DTaP-IPV/Hib vaccine)
Pneumo 23 (Pneumococcal infections)
Quadracel (DTaP-IPV/Hib vaccine)
Shanchol (Cholera vaccine)
Synercid (Quinupristin/dalfopristin), marketed by Pfizer.
Tenivac (Tetanus vaccine)
Tripedia (DPT vaccine), discontinued in 2012.
Tubersol (Tuberculosis vaccine)
Typhim Vi (Typhoid fever)
Vaccin Tetanique Pasteur (Tetanus vaccine)
Viral diseases:
ACAM 2000 (Smallpox vaccine), eradicated in 1980 (vaccine produced as a measure in response to the threat of bioterrorism).
Avaxim (Hepatitis A vaccine)
Flublok (Influenza vaccine)
Fluzone (Influenza vaccine)
Hbvaxpro (Hepatitis B vaccine)
Imovax Polio (Polio vaccine)
Imovax Rabies (Rabies vaccine)
Ipol (Polio vaccine)
Ixiaro (Japanese encephalitis)
M-M-RVaxPro (MMR vaccine)
Rouvax (Measles vaccine)
Rudivax (Rubella vaccine)
Stamaril (Yellow fever vaccine)
Vaxigrip (Influenza vaccine)
YF-VAX (Yellow fever vaccine)
– Metabolic
Actonel (Risedronic acid), for osteoporosis and Paget's disease, now owned by Allergan.
Renagel (Sevelamer) hydrochloride, for end stage renal disease.
Renvela (Sevelamer) hydrochloride, for end stage renal disease.
– Neurology
Ambien (Zolpidem), for insomnia.
Ambien CR (Zolpidem), for insomnia.
Aubagio (Teriflunomide), for multiple sclerosis.
Depakine (Valproic acid), for epilepsy, now owned by AbbVie.
Depakote (Valproate semisodium), for epilepsy, now owned by AbbVie.
Hyalgan (Sodium hyaluronate), for blood tests.
Lemtrada (Alemtuzumab), for multiple sclerosis.
Pediapred (Prednisolone), for multiple sclerosis.
Rilutek (Riluzole), for ALS.
Sabril (Vigabatrin), for epilepsy, marketed by Lundbeck.
– Oncology
Anzemet (Dolasetron), for nausea and vomiting.
Campath (Alemtuzumab), for multiple sclerosis.
Caprelsa (Vandetanib), for breast, colorectal cancer and female infertility.
Clolar (Clofarabine), for leukemia.
Clomid (Clomifene), for female infertility.
Dupixent (Dupilumab), for eczema, marketed by Regeneron.
Eligard (Leuprorelin), for prostate cancer, marketed by Astellas.
Elitek (Rasburicase), for the treatment to help stop uric acid.
Eloxatin (Oxaliplatin), for colorectal cancer.
Fludara (Fludarabine), for leukemia.
Gliadel Wafer (Carmustine), for cancer, now owned by Arbor Pharmaceuticals.
Jevtana (Cabazitaxel), for prostate cancer.
Kevzara (Sarilumab), for blood tests, lung and prostate cancer, marketed by Regeneron.
Leukine (Sargramostim), for neutropenia.
Libtayo (Cemiplimab), for squamous cell skin cancer, marketed by Regeneron.
Mozobil (Plerixafor), macrocycle, approved by the FDA for peripheral blood stem cell mobilizer for non-Hodgkin's lymphoma and multiple myeloma in December 2008.[89]
Oforta (Fludarabine), for leukemia.
Taxotere (Docetaxel), for breast, lung and prostate cancer.
Uroxatral (Alfuzosin), for benign prostatic hyperplasia.
Zaltrap (Aflibercept), recombinant fusion protein, approved in metastatic colorectal cancer in combination with other agents in 2012, marketed by Regeneron.[27]
– Other
Aldurazyme (Laronidase), for hurler syndrome.
Aplenzin (Bupropion), for depression and quit smoking.
Captique (Dermal filler), for facial wrinkles.
Carticel (Knee cartilage replacement therapy), for knee pain.
Cerdelga (Eliglustat), for type 1 gaucher disease.
Ceredase (Alglucerase), for Gaucher's disease.
Cerezyme (Imiglucerase), for Gaucher's disease.
Elaprase (Idursulfase), marketed by Shire.
Epicel (cultered epidermal autografts), for thickness burns.
Fabrazyme (Agalsidase), for Fabry disease.
Flagyl (Metronidazole), for vaginal infections, marketed by Pfizer.
Hylaform Plus (Injectable filler), for facial wrinkles.
Lumizyme (Alglucosidase alfa), for Pompe disease.
Myozyme (Alglucosidase alfa), for Pompe disease.
Sculptra (Polylactic acid), for facial fat loss.
Thyrogen (Thyroid-stimulating hormone), for thyroid cancer.
– Over the counter
Allegra (Fexofenadine), for allergic rhinitis.
Buscopan (Hyoscine butylbromide), for abdominal pain.
Maalox (Calcium carbonate), an antacid.
Nasacort (Triamcinolone), for allergic rhinitis.
Novaldol (Paracetamol), for pain and fever.
Unisom (Doxylamine), for night-time allergy and cold relief.
Xyzal (Levocetirizine), for allergic rhinitis, marketed by UCB.
– Pain
Bi-profined (Ketoprofen), for pain.
Solpadol (Codeine), for chronic pain.
– Respiratory and inflammatory diseases
Atrovent (Ipratropium bromide), for asthma, marketed by Boehringer Ingelheim.
Azmacort (Triamcinolone), for asthma.
Dynabac (Dirithromycin), for acute bacterial exacerbations.
Ketek (Telithromycin), for community acquired pneumonia.
Priftin (Rifapentine), for tuberculosis.
Rifadin (Rifampin), for tuberculosis.
Rifamate (Isoniazid/rifampicin), for tuberculosis.
Rifater (Rifampicin/isoniazid/pyrazinamide), for tuberculosis.
Tilade (Nedocromil), for asthma.
Zagam (Sparfloxacin), for chronic bronchitis.
Zemaira (Alpha-1 antitrypsin), for chronic augmentation, now owned by CSL Behring.
– Rheumatology
Arava (Leflunomide), for rheumatoid and psoriatic arthritis.
Kevzara (Sarilumab), for blood tests, lung and prostate cancer, marketed by Regeneron.
Primaquine (Primaquine), for malaria.
Synvisc (Hyaluronic acid), for knee pain.
– Urology
Ditropan XL (Oxybutynin chloride), for bladder relief, marketed by Janssen.
Eligard (Leuprorelin), for prostate cancer, marketed by Astellas.
Flomax (Tamsulosin), for bladder relief, marketed by Astellas.